Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National ...
Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National ...
Linfoma no Hodgkin en adultos: Tratamiento (PDQ®) - National ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Linfoma</strong> <strong>no</strong> <strong>Hodgkin</strong> <strong>en</strong> <strong>adultos</strong>: Tratami<strong>en</strong>to (<strong>PDQ®</strong>) - <strong>National</strong> Cancer Institute<br />
based on the expression of six g<strong>en</strong>es. N Engl J Med 350 (18): 1828-37, 2004. [PUBMED Abstract]<br />
107. Abramson JS, Shipp MA: Advances in the biology and therapy of diffuse large B-cell lymphoma: moving<br />
toward a molecularly targeted approach. Blood 106 (4): 1164-74, 2005. [PUBMED Abstract]<br />
108. de Jong D, Ros<strong>en</strong>wald A, Chhanabhai M, et al.: Immu<strong>no</strong>histochemical prog<strong>no</strong>stic markers in diffuse large<br />
B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study<br />
from the Lun<strong>en</strong>burg Lymphoma Biomarker Consortium. J Clin Oncol 25 (7): 805-12, 2007. [PUBMED Abstract]<br />
109. Fu K, Weis<strong>en</strong>burger DD, Choi WW, et al.: Addition of rituximab to standard chemotherapy improves the<br />
survival of both the germinal c<strong>en</strong>ter B-cell-like and <strong>no</strong>n-germinal c<strong>en</strong>ter B-cell-like subtypes of diffuse<br />
large B-cell lymphoma. J Clin Oncol 26 (28): 4587-94, 2008. [PUBMED Abstract]<br />
110. L<strong>en</strong>z G, Staudt LM: Aggressive lymphomas. N Engl J Med 362 (15): 1417-29, 2010. [PUBMED Abstract]<br />
111. Glantz MJ, Cole BF, Recht L, et al.: High-dose intrave<strong>no</strong>us methotrexate for pati<strong>en</strong>ts with <strong>no</strong>nleukemic<br />
leptom<strong>en</strong>ingeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol 16 (4): 1561-7, 1998. [PUBMED<br />
Abstract]<br />
112. Fisher RI, Gay<strong>no</strong>r ER, Dahlberg S, et al.: Comparison of a standard regim<strong>en</strong> (CHOP) with three int<strong>en</strong>sive<br />
chemotherapy regim<strong>en</strong>s for advanced <strong>no</strong>n-<strong>Hodgkin</strong>'s lymphoma. N Engl J Med 328 (14): 1002-6, 1993.<br />
[PUBMED Abstract]<br />
113. Bernstein SH, Unger JM, Leblanc M, et al.: Natural history of CNS relapse in pati<strong>en</strong>ts with aggressive <strong>no</strong>n-<br />
<strong>Hodgkin</strong>'s lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group. J<br />
Clin Oncol 27 (1): 114-9, 2009. [PUBMED Abstract]<br />
114. van Besi<strong>en</strong> K, Ha CS, Murphy S, et al.: Risk factors, treatm<strong>en</strong>t, and outcome of c<strong>en</strong>tral nervous system<br />
recurr<strong>en</strong>ce in adults with intermediate-grade and immu<strong>no</strong>blastic lymphoma. Blood 91 (4): 1178-84, 1998.<br />
[PUBMED Abstract]<br />
115. Delabie J, Vand<strong>en</strong>berghe E, K<strong>en</strong>nes C, et al.: Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic<br />
<strong>en</strong>tity possibly related to lymphocyte predominant <strong>Hodgkin</strong>'s disease, paragranuloma subtype. Am J Surg<br />
Pathol 16 (1): 37-48, 1992. [PUBMED Abstract]<br />
116. Acht<strong>en</strong> R, Verhoef G, Vanuytsel L, et al.: T-cell/histiocyte-rich large B-cell lymphoma: a distinct<br />
clinicopathologic <strong>en</strong>tity. J Clin Oncol 20 (5): 1269-77, 2002. [PUBMED Abstract]<br />
117. Bouabdallah R, Mounier N, Guettier C, et al.: T-cell/histiocyte-rich large B-cell lymphomas and classical<br />
diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis. J<br />
Clin Oncol 21 (7): 1271-7, 2003. [PUBMED Abstract]<br />
118. Ghesquières H, Berger F, Felman P, et al.: Clinicopathologic characteristics and outcome of diffuse large<br />
B-cell lymphomas pres<strong>en</strong>ting with an associated low-grade compon<strong>en</strong>t at diag<strong>no</strong>sis. J Clin Oncol 24 (33):<br />
5234-41, 2006. [PUBMED Abstract]<br />
119. Lazzari<strong>no</strong> M, Orlandi E, Paulli M, et al.: Primary mediastinal B-cell lymphoma with sclerosis: an<br />
aggressive tumor with distinctive clinical and pathologic features. J Clin Oncol 11 (12): 2306-13, 1993.<br />
[PUBMED Abstract]<br />
120. Kirn D, Mauch P, Shaffer K, et al.: Large-cell and immu<strong>no</strong>blastic lymphoma of the mediastinum:<br />
prog<strong>no</strong>stic features and treatm<strong>en</strong>t outcome in 57 pati<strong>en</strong>ts. J Clin Oncol 11 (7): 1336-43, 1993. [PUBMED<br />
Abstract]<br />
121. Ais<strong>en</strong>berg AC: Primary large-cell lymphoma of the mediastinum. J Clin Oncol 11 (12): 2291-4, 1993.<br />
[PUBMED Abstract]<br />
122. Abou-Elella AA, Weis<strong>en</strong>burger DD, Vose JM, et al.: Primary mediastinal large B-cell lymphoma: a<br />
clinicopathologic study of 43 pati<strong>en</strong>ts from the Nebraska Lymphoma Study Group. J Clin Oncol 17 (3):<br />
784-90, 1999. [PUBMED Abstract]<br />
123. Cazals-Hatem D, Lepage E, Brice P, et al.: Primary mediastinal large B-cell lymphoma. A<br />
clinicopathologic study of 141 cases compared with 916 <strong>no</strong>nmediastinal large B-cell lymphomas, a GELA<br />
("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol 20 (7): 877-88, 1996. [PUBMED<br />
Abstract]<br />
124. Popat U, Przepiork D, Champlin R, et al.: High-dose chemotherapy for relapsed and refractory diffuse large<br />
B-cell lymphoma: mediastinal localization predicts for a favorable outcome. J Clin Oncol 16 (1): 63-9,<br />
file:///Users/mauriciolema/Docum<strong>en</strong>ts/MLMGuias_09_<strong>Linfoma</strong>No<strong>Hodgkin</strong>.webarchive<br />
29/09/11 6:15<br />
Página 19 de 61
Change language